Non-opioid Pain Relief
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,078
NCT06049095
A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 17, 2023
Completion: Feb 28, 2026
NCT06554574
A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants
Start: Sep 3, 2024
Completion: Jun 16, 2025
NCT06600607
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
Phase: Early Phase 1
Start: Oct 7, 2024
Completion: Oct 27, 2024
NCT06774625
This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars
Phase: Phase 2
Start: Dec 19, 2024
Completion: Aug 8, 2025
NCT06972212
Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults
Start: Jun 4, 2025
Completion: Jun 28, 2025
NCT07102459
An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
Start: Jul 24, 2025
Completion: Jan 31, 2026
NCT07110610
Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
Start: Sep 3, 2025
Completion: Jul 31, 2026
Loading map...